{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:44:31Z","timestamp":1683089071729},"reference-count":35,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.3928\/0090-4481-20050101-14","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T18:26:28Z","timestamp":1401215188000},"page":"62-68","source":"Crossref","is-referenced-by-count":7,"title":["Respiratory Syncytial Virus: Old Challenges and New Approaches"],"prefix":"10.3928","volume":"34","author":[{"given":"Susana","family":"Ch\u00e1vez-Bueno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan S","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Leader S Kohlhase K. Recent trends severe respiratory syncytial virus among US infants 1997 to 2000. J 2003;143(5 Suppl):S127-132.","DOI":"10.1067\/S0022-3476(03)00510-9"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Sigurs N Gustafsson PM Bjarnason R et Severe respiratory syncytial virus tis in infancy and asthma and allergy at 13. Am J Respir Crit Care Med. 2004 ahead of print].","DOI":"10.1164\/rccm.200406-730OC"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Stein RT Sherrill D Morgan WJ et al. piratory syncytial virus in early life and of wheeze and allergy by age 13 Lancet. 1999 354(9178):541-545.","DOI":"10.1016\/S0140-6736(98)10321-5"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Shay DK Holraan RC Newman RD et Bronchiolitis-associated among US children 1980-1996. JAMA. 282(15): 1440-1446.","DOI":"10.1001\/jama.282.15.1440"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Iwane MK Edwards KM Szilagyi PG et Population-based surveillance for tions associated with respiratory virus influenza virus and viruses among young children. 2004; 13(6): 758- 1 764.","DOI":"10.1542\/peds.113.6.1758"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Thompson WW Shay DK Weintraub E et Mortality associated with influenza and ratory syncytial virus in the United JAMA. 2003;289(2): 179-186.","DOI":"10.1001\/jama.289.2.179"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Simoes EA. Environmental and risk factors for respiratory syncytial lower respiratory tract disease. J 2003; 143(5 Suppl):S118-126.","DOI":"10.1067\/S0022-3476(03)00511-0"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Garofalo RP Hinte KH Hill V Ogra Welliver RC Sr. Production of gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol. 2004;73(2): 289-94.","DOI":"10.1002\/jmv.20089"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. van Benten U van Drunen CM Kooproan LP et al. RSV-induced bronchiolitis but not respiratory tract infection is accompanied by an increased nasal IL-18 response. J Virol. 2003;71(2):290-297.","DOI":"10.1002\/jmv.10482"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. van Schaik SM Tristram DA Nagpal IS al. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol. 1999; 103(4):630-636.","DOI":"10.1016\/S0091-6749(99)70235-6"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Garofalo RP Patti J. Hintz KA et al. Macrophage inflammatory protein- 1 alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis. 2001; 184(4): 393-399.","DOI":"10.1086\/322788"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Sheeran P Jafri H Carubelli C et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J. 1999; 18(2): 115-122.","DOI":"10.1097\/00006454-199902000-00007"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Jafri HS Chavez-Bueno S Mejias A et al. Respiratory syncytial virus induces pneumonia cytokine response airway obstruction and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis. 2004; 189(10): 1856-1865.","DOI":"10.1086\/386372"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Schwarze J O'Donnell DR Rohwedder A Openshaw PJ. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med. 2004; 169(7):801-805.","DOI":"10.1164\/rccm.200308-1203OC"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. Seemungal T Harper-Owen R Bhowmik A et al. Respiratory viruses symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164(9): 1618-1623.","DOI":"10.1164\/ajrccm.164.9.2105011"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Cubie HA1 Duncan LA Marshall LA Smith NM. Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr Pathol Lab Med. 1997; 17(6):927-938.","DOI":"10.3109\/15513819709168756"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Groothuis JR Simoes EA Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993;329(21):15241530.","DOI":"10.1056\/NEJM199311183292102"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study group. Pediatrics. 1997;99(1):93-99.","DOI":"10.1542\/peds.99.1.93"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. Simoes EA Sondheimer HM Top FH Jr et al. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr. 1998;133(4):492-499.","DOI":"10.1016\/S0022-3476(98)70056-3"},{"key":"e_1_3_1_21_1","doi-asserted-by":"crossref","unstructured":"20. Palivizumab a Humanized Respiratory Syncytial Virus Monoclonal Antibody Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics. 1998; 102(3):53 1-537.","DOI":"10.1542\/peds.102.3.531"},{"key":"e_1_3_1_22_1","doi-asserted-by":"crossref","unstructured":"21. Feltes TF Cabalka AK Meissner HC et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143(4):532-540.","DOI":"10.1067\/S0022-3476(03)00454-2"},{"key":"e_1_3_1_23_1","doi-asserted-by":"crossref","unstructured":"22. Malley R DeVincenzo J Ramilo O et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis. 1998; 178(6):1555-1561.","DOI":"10.1086\/314523"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"23. Saez-Llorens X Moreno MT Ramilo O et al. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. Pediatr Infect Dis J. 2004;23(8):707-712.","DOI":"10.1097\/01.inf.0000133165.85909.08"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"24. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003; 112(6 Pt 1): 1442-1446.","DOI":"10.1542\/peds.112.6.1442"},{"key":"e_1_3_1_26_1","unstructured":"25. Mejias A Chavez-Bueno S Rios AM et al. Comparative effect of anti-respiratory syncytial virus (RSV) monoclonal antibodies on viral replication and disease severity in the RSV murine model. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; October 30-November 2 2004; Washington DC. Abstract No. V1687:472."},{"key":"e_1_3_1_27_1","doi-asserted-by":"crossref","unstructured":"26. Mejias A Chavez-Bueno S Rios AM et al. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation airway obstruction and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004;48(5):18111822.","DOI":"10.1128\/AAC.48.5.1811-1822.2004"},{"key":"e_1_3_1_28_1","unstructured":"27. Simoes EAF Carbonell-Estrany X Kimpen J et al. Palivizumab use decreases risk of recurrent wheezing in preterm children. Presented at: 1 4th European Respiratory Society Annual Congress; September 4-8 2004; Glasgow Scotland. Abstract No. 1349."},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"28. Groothuis JR Woodin KA Katz R et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr. 1990; 117(5)792-798.","DOI":"10.1016\/S0022-3476(05)83347-5"},{"key":"e_1_3_1_30_1","doi-asserted-by":"crossref","unstructured":"29. Smith DW Frankel LR Mathers LH Tang AT Ariagno RL and Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med. l991;325(1):24-29.","DOI":"10.1056\/NEJM199107043250105"},{"key":"e_1_3_1_31_1","doi-asserted-by":"crossref","unstructured":"30. Randolph AG Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview. Arch Pediatr Adolesc Med. 1996;150(9):942-947.","DOI":"10.1001\/archpedi.1996.02170340056011"},{"key":"e_1_3_1_32_1","doi-asserted-by":"crossref","unstructured":"31. Law BJ Wang EE MacDonald N et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Pediatrics. 1997;99(3):E7.","DOI":"10.1542\/peds.99.3.e7"},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"32. Buckingham SC Jafri HS Bush AJ et al. A randomized double-blind placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis. 2002;185(9):1222-1228.","DOI":"10.1086\/340024"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","unstructured":"33. Dobson JV Stephens-Groff SM McMahon SR et al. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics. 1998; 101(3 Pt 1):361-368.","DOI":"10.1542\/peds.101.3.361"},{"key":"e_1_3_1_35_1","doi-asserted-by":"crossref","unstructured":"34. Wainwright C Altamirano L Cheney M et al. A multicenter randomized double-blind controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med. 2003;349(1):27-35.","DOI":"10.1056\/NEJMoa022226"},{"key":"e_1_3_1_36_1","unstructured":"35. Mejias A Chavez-Bueno S Rios AM et al. [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention.]. An Pediatr (Bare). 2004;61(3):252-60."}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/0090-4481-20050101-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:19:32Z","timestamp":1683087572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0090-4481-20050101-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.3928\/0090-4481-20050101-14"],"URL":"https:\/\/doi.org\/10.3928\/0090-4481-20050101-14","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}